Collection of white blood cell-reduced plasma by apheresis

Transfusion

Volumn 44, Issue 6, 2004, Pages 917-923

  Vrielink, Hans ^a   Van Der Meer, Pieter F ^a  

^a Sanquin Bloedbank Regio Noordwest Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; ARTICLE; CELL COUNT; COMPUTER PROGRAM; CONTAMINATION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; HUMAN; HUMAN CELL; LEUKOCYTE; PLASMA; PLASMAPHERESIS; STATISTICAL ANALYSIS;

ADULT; BLOOD CELL COUNT; BLOOD DONORS; EQUIPMENT DESIGN; HUMANS; LEUKOCYTE COUNT; PLASMA; PLASMAPHERESIS; SOFTWARE;

EID: 2942592388     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03314.x     Document Type: Article

References (29)

1. Perrotta PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev 2001;15:69-83.
2. Turner ML. Variant Creutzfeldt-Jakob disease and blood transfusion. Curr Opin Hematol 2001;8:372-9.
3. Beckman N, Sher G, Masse M, et al. Review of the quality monitoring methods employed by countries using or implementing universal leukodepletion. BEST Working Party of the ISBT. Transfus Med Rev 2004;18:25-35.
4. Riggert J, Schwartz DW, Wieding JU, et al. Prestorage inline filtration of whole blood for obtaining white cell-reduced blood components. Transfusion 1997;37:1039-44.
5. Van der Meer P, Pietersz R, Hinloopen B, et al. Automated separation of whole blood in top and bottom bags into components using the Compomat G4. Vox Sang 1999;76:90-9.
6. Valbonesi M, Bruni R, Florio G, et al. Cellular contamination of plasma collected with various apheresis systems. Transfus Apheresis Sci 2001;24:91-4.
7. Guide to the preparation, use, quality assurance of blood components. 9th ed. Strasbourg, France: Council of Europe Publishing; 2003:138.
8. Hiruma K, Okuyama Y. Effect of leucocyte reduction on the potential alloimmunogenicity of leucocytes in fresh-frozen plasma products. Vox Sang 2001;80:51-6.
9. Ferrara GB, Tosi RM, Azzolina G, et al. The production of anti HL-A cytotoxic antisera through planned immunization by intravenous injection of small aliquots of whole blood. I. Immunization of unrelated recipients. Tissue Antigens 1972;2:359-73.
10. Heiden M, Seitz R. Quality of therapeutic plasma-requirements for marketing authorization. Thromb Res 2002;107(Suppl 1):547.
11. Burnouf T, Kappelsberger C, Frank K, Burkhardt T. Protein composition and activation markers in plasma collected by three apheresis procedures. Transfusion 2003;43:1223-30.
12. Frank K, Galle G, Rummler S, et al. Measurement of quality of FFP in consideration of possible immunization of patients by WBC or PLT antigens. Ther Apher Dial 2003;7:A9.
13. Perseghin P, Capra M, Baldini V, Sciorelli G. Bradykinin production during donor plasmapheresis procedures. Vox Sang 2001;81:24-8.
14. Cardigan R, Sutherland J, Garwood M, et al. The effect of leucocyte depletion on the quality of fresh-frozen plasma. Br J Haematol 2001;114:233-40.
15. Rapaille A, Moore G, Siquet J, et al. Prestorage leukocyte reduction with in-line filtration of whole blood: evaluation of red cells and plasma storage. Vox Sang 1997;73:28-35.
16. Björk P, Forsberg PO, Falaize S, Leuenberger C. Clinical evaluation of a new high separation bowl for plasmapheresis. Vox Sang 2002;83(S2):185.
17. Dumont LJ, Dzik VM, Rebulla P, Brandwein H. Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfusion 1996;36:11-20.
18. Gunson HH, Stratton F, Cooper DG, Rawlinson VI. Primary immunization of Rh-negative volunteers. Br Med J 1970;696:593-5.
19. Jakobowicz R, Williams L, Silberman F. Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood. Vox Sang 1972;23:376-81.
20. McBride JA, O'Hoski P, Barnes CC, et al. Rhesus alloimmunization following intensive plasma exchange. Transfusion 1983;23:352-4.
21. Wolfowitz E, Shechter Y. More about alloimmunization by transfusion of fresh-frozen plasma. Transfusion 1984;24:544.
22. Salonvaara M, Eronen J, Helminen P, et al. Small doses of cryopreserved O RhD positive leukocyte-reduced red cells are not effective in primary immunization of RhD negative voluntary men. Vox Sang 2002;83(Suppl 2):65.
23. Blumberg N, Heal JM, Gettings KF. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion 2003;43:945-52.
24. Rose L, AuBuchon J, Auger C, et al. Improved separation in plasmapheresis using the high separation core. Vox Sang 2002;83(S2):185.
25. Wieding JU, Vehmeyer K, Dittman J, et al. Contamination of fresh-frozen plasma with viable white cells and proliferable stem cells. Transfusion 1994;34:185-6.
26. Rider JR, Winter MA, Payrat JM, et al. Leucocytes can be eliminated from plasma by filtration prior to viral inactivation with methylene blue. Vox Sang 1998;74:209-10.
27. Willis JI, Lown JA, Simpson MC, Erber WN. White cells in fresh-frozen plasma: evaluation of a new white cell-reduction filter. Transfusion 1998;38:645-9.
28. Bernvil SS, Abdulatiff M, al-Sedairy S, et al. Fresh frozen plasma contains viable progenitor cells-should we irradiate? Vox Sang 1994;67:405.
29. Nielsen HJ, Reimert C, Pedersen AN, et al. Leucocyte-derived bioactive substances in fresh frozen plasma. Br J Anaesth 1997;78:548-52.